CAPITOL COUNSEL LLC

Lobbying for AMGEN INC. · Human therapeutics company in the biotechnology industry

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 18, 2025

Lobbying activity 1

Medicare/Medicaid

Medicare Part B coverage and reimbursement issues; Medicare Part D coverage issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.